These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9100079)

  • 41. "In vitro" antimycotic activity of fenticonazole (Rec 15/1476).
    Costa AL
    Mykosen; 1982 Jan; 25(1):47-52. PubMed ID: 7040949
    [No Abstract]   [Full Text] [Related]  

  • 42. Laboratory techniques alternative to in vivo experiments for studying the liberation, penetration and fungicidal action of topical antimycotic agents in the skin, including ciclopiroxolamine.
    Dittmar W; Jović N
    Mykosen; 1987 Jul; 30(7):326-42. PubMed ID: 3657856
    [No Abstract]   [Full Text] [Related]  

  • 43. [In vitro pharmacological study of fluconazole. Evaluation of an antifungal assay].
    Duval F; Lavarde V
    Pathol Biol (Paris); 1993 May; 41(5):469-73. PubMed ID: 8414680
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The dermatopharmacologic profile of ciclopirox 8% nail lacquer.
    Bohn M; Kraemer K
    J Am Podiatr Med Assoc; 2000; 90(10):491-4. PubMed ID: 11107709
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Broad spectrum antifungal agents in otomycosis.
    Bassiouny A; Kamel T; Moawad MK; Hindawy DS
    J Laryngol Otol; 1986 Aug; 100(8):867-73. PubMed ID: 3746101
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro antifungal activity of sertaconazole nitrate against recent isolates of onychomycosis causative agents.
    Carrillo-Muñoz AJ; Quindós G; Del Valle O; Santos P; Giusiano G; Guardia C; Eraso E; Ezkurra PA; Tur-Tur C; Hernández-Molina JM
    J Chemother; 2008 Aug; 20(4):521-3. PubMed ID: 18676237
    [No Abstract]   [Full Text] [Related]  

  • 47. [Antifungal activity of the components of the drug cerbiden of plant origin].
    Smirnov VV; Bondarenko AS; Gladun NP
    Mikrobiol Z; 2003; 65(4):17-22. PubMed ID: 14618782
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antifungal activity of fluid extract and essential oil from anise fruits (Pimpinella anisum L., Apiaceae).
    Kosalec I; Pepeljnjak S; Kustrak D
    Acta Pharm; 2005 Dec; 55(4):377-85. PubMed ID: 16375827
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The relationship between the antimycotic activity of hydrogen peroxide and fungal catalase activity].
    Schönborn C; Ludewig R
    Mykosen; 1968 Jan; 11(1):77-82. PubMed ID: 5761188
    [No Abstract]   [Full Text] [Related]  

  • 50. [In vitro antifungal activities of lanoconazole against stock cultures and clinical isolates of Candida albicans].
    Niwano Y; Ohmi T; Kanai K; Hamaguchi H; Uchida K; Yamaguchi H
    Jpn J Antibiot; 1995 Jan; 48(1):140-5. PubMed ID: 7699837
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Antifungal activity of sulfonated shale oils].
    Listemann H; Schölermann A; Meigel W
    Arzneimittelforschung; 1993 Jul; 43(7):784-8. PubMed ID: 8103661
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Physicochemical modification of the excretion product of Saccharomyces cerevisiae killer strains results in fungicidal activity against Candida albicans and Tricophyton mentagrophytes.
    Bracesco N; Salvo VA; Carrau FM; Nunes E
    FEMS Microbiol Lett; 2006 Mar; 256(1):132-6. PubMed ID: 16487330
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An atypical active cell death process underlies the fungicidal activity of ciclopirox olamine against the yeast Saccharomyces cerevisiae.
    Almeida B; Sampaio-Marques B; Carvalho J; Silva MT; Leão C; Rodrigues F; Ludovico P
    FEMS Yeast Res; 2007 May; 7(3):404-12. PubMed ID: 17233764
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Spectrum of in vitro antifungal activity of ditiocarb sodium.
    Allerberger F; Roberts G; Reisinger E; Dierich MP
    Arzneimittelforschung; 1991 Apr; 41(4):443-8. PubMed ID: 1650228
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative in vitro activity of antimycotic agents against pathogenic vaginal yeast isolates.
    Lynch ME; Sobel JD
    J Med Vet Mycol; 1994; 32(4):267-74. PubMed ID: 7983571
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis and characterization of some hydroxypyridone derivatives and their evaluation as antimicrobial agents.
    Faidallah HM; Rostom SA; Khan KA; Basaif SA
    J Enzyme Inhib Med Chem; 2013 Oct; 28(5):926-35. PubMed ID: 22803670
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vitro susceptibility testing of dermatophytes: comparison of disk diffusion and reference broth dilution methods.
    Karaca N; Koç AN
    Diagn Microbiol Infect Dis; 2004 Apr; 48(4):259-64. PubMed ID: 15062918
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interactions between killer yeasts and pathogenic fungi.
    Walker GM; McLeod AH; Hodgson VJ
    FEMS Microbiol Lett; 1995 Apr; 127(3):213-22. PubMed ID: 7758935
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro activity of ME1401, a new antifungal agent.
    Yamaguchi H; Uchida K; Hiratani T; Hara T; Fukuyasu H; Kazuno Y; Inouye S
    Antimicrob Agents Chemother; 1986 Nov; 30(5):705-12. PubMed ID: 3800346
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Antifungal activity of pimaricin].
    Masako Y
    J Antibiot B; 1966 Apr; 19(1):28-30. PubMed ID: 5298049
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.